Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. It has an agreement with NoiseFigure Research, Inc. to develop next generation of its proprietary microchip. Autonomix Medical, Inc. was incorporated in 2014 and is based in The Woodlands, Texas.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [11/06/2026 10:29 PST] Autonomix Medical, Inc. (NASDAQ:amix), Down By 100% ($2.07) From $2.07 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [10/28/2026 07:09 PDT] amix Expected to Trade Down After Bearish Patterns Develop
• [10/15/2026 10:30 PDT] Autonomix Medical, Inc. (NASDAQ:amix), Down By 100% ($3.75) From $3.75 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [09/30/2026 06:38 PDT] amix Expected to Trade Down After Bearish Patterns Develop
• [09/28/2026 07:48 PDT] amix Expected to Trade Up After Bullish Patterns Develop
• [09/17/2026 05:45 PDT] amix Expected to Trade Up After Bullish Patterns Develop